• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Hamilton Lane Incorporated (Amendment)

    1/25/24 4:59:24 PM ET
    $HLNE
    Investment Managers
    Finance
    Get the next $HLNE alert in real time by email
    SC 13G/A 1 us4074971064_012524.txt us4074971064_012524.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 5) HAMILTON LANE INC -------------------------------------------------------- (Name of Issuer) Class A Common Stock -------------------------------------------------------- (Title of Class of Securities) 407497106 -------------------------------------------------------- (CUSIP Number) December 31, 2023 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 407497106 (1)Names of reporting persons. BlackRock, Inc. (2) Check the appropriate box if a member of a group (a) [ ] (b) [X] (3) SEC use only (4) Citizenship or place of organization Delaware Number of shares beneficially owned by each reporting person with: (5) Sole voting power 3116455 (6) Shared voting power 0 (7) Sole dispositive power 3217043 (8) Shared dispositive power 0 (9) Aggregate amount beneficially owned by each reporting person 3217043 (10) Check if the aggregate amount in Row (9) excludes certain shares (11) Percent of class represented by amount in Row 9 8.3% (12) Type of reporting person HC Item 1. Item 1(a) Name of issuer: ----------------------------------------------------------------------- HAMILTON LANE INC Item 1(b) Address of issuer's principal executive offices: ----------------------------------------------------------------------- 110 WASHINGTON STREET, SUITE 1300 CONSHOHOCKEN PA 19428 Item 2. 2(a) Name of person filing: ---------------------------------------------------------------------- BlackRock, Inc. 2(b) Address or principal business office or, if none, residence: ----------------------------------------------------------------------- BlackRock, Inc. 50 Hudson Yards New York, NY 10001 2(c) Citizenship: -------------------------------------------------------------------- See Item 4 of Cover Page 2(d) Title of class of securities: ------------------------------------------------------------------- Class A Common Stock 2(e) CUSIP No.: See Cover Page Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a: [ ] Broker or dealer registered under Section 15 of the Act; [ ] Bank as defined in Section 3(a)(6) of the Act; [ ] Insurance company as defined in Section 3(a)(19) of the Act; [ ] Investment company registered under Section 8 of the Investment Company Act of 1940; [ ] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); [ ] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); [X] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940; [ ] A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J); [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: Item 4. Ownership Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. Amount beneficially owned: 3217043 Percent of class 8.3% Number of shares as to which such person has: Sole power to vote or to direct the vote 3116455 Shared power to vote or to direct the vote 0 Sole power to dispose or to direct the disposition of 3217043 Shared power to dispose or to direct the disposition of 0 Item 5. Ownership of 5 Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [ ]. Item 6. Ownership of More than 5 Percent on Behalf of Another Person If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. Various persons have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of the common stock of HAMILTON LANE INC. No one person's interest in the common stock of HAMILTON LANE INC is more than five percent of the total outstanding common shares. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. See Exhibit A Item 8. Identification and Classification of Members of the Group If a group has filed this schedule pursuant to Rule 13d-1(b)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identity of each member of the group. Item 9. Notice of Dissolution of Group Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5. Item 10. Certifications By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: January 25, 2024 BlackRock, Inc. Signature: Spencer Fleming ------------------------------------------- Name/Title Attorney-In-Fact The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing person, evidence of the representative's authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature. Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001). Exhibit A Subsidiary BlackRock Advisors, LLC Aperio Group, LLC BlackRock (Netherlands) B.V. BlackRock Institutional Trust Company, National Association BlackRock Asset Management Ireland Limited BlackRock Financial Management, Inc. BlackRock Japan Co., Ltd. BlackRock Asset Management Schweiz AG BlackRock Investment Management, LLC BlackRock Investment Management (UK) Limited BlackRock Asset Management Canada Limited BlackRock Investment Management (Australia) Limited BlackRock Fund Advisors BlackRock Fund Managers Ltd *Entity beneficially owns 5% or greater of the outstanding shares of the security class being reported on this Schedule 13G. Exhibit B POWER OF ATTORNEY The undersigned, BlackRock, Inc., a corporation duly organized under the laws of the State of Delaware, United States (the "Company"), does hereby make, constitute and appoint each of Eric Andruczyk, Richard Cundiff, R. Andrew Dickson, III, Spencer Fleming, Daniel Goldmintz, Laura Hildner, Elizabeth Kogut, David Maryles, Christopher Meade, Una Neary, Charles Park, Daniel Riemer, David Rothenberg and Brenda Schulz, acting severally, as its true and lawful attorneys-in-fact, for the purpose of, from time to time, executing, in its name and on its behalf and on behalf of its direct and indirect subsidiaries, any and all documents, certificates, instruments, statements, filings, agreements and amendments (collectively, "documents") determined by such person to be necessary or appropriate to comply with ownership or control-person reporting requirements imposed by any United States or non-United States governmental or regulatory authority, including, without limitation, Schedules 13D and 13G and Forms 3, 4, 5, 13F and 13H and any amendments to any of the foregoing as may be required to be filed with the Securities and Exchange Commission, and delivering, furnishing or filing any such documents with the appropriate governmental or regulatory authority or other person, and giving and granting to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully and to all intents and purposes as the Company and/or its direct and indirect subsidiaries, as applicable, might or could do if personally present by one of its authorized signatories, hereby ratifying and confirming all that said attorney-in-fact shall lawfully do or cause to be done by virtue hereof. Any such determination by an attorney-in-fact named herein shall be conclusively evidenced by such person's execution, delivery, furnishing or filing of the applicable document. This power of attorney shall expressly revoke the power of attorney dated 2nd day of January, 2019 in respect of the subject matter hereof, shall be valid from the date hereof and shall remain in full force and effect until either revoked in writing by the Company, or, in respect of any attorney-in-fact named herein, until such person ceases to be an employee of the Company or one of its affiliates. IN WITNESS WHEREOF, the undersigned has caused this power of attorney to be executed as of this 30th day of April, 2023. BlackRock, Inc. By: /s/ R. Andrew Dickson, III Name: R. Andrew Dickson, III Title: Corporate Secretary
    Get the next $HLNE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HLNE

    DatePrice TargetRatingAnalyst
    1/21/2025$186.00Perform → Outperform
    Oppenheimer
    1/6/2025$139.00Neutral → Sell
    Goldman
    9/12/2024$156.00Equal Weight
    Wells Fargo
    4/11/2024$115.00Overweight → Neutral
    JP Morgan
    1/11/2024Outperform → Perform
    Oppenheimer
    5/26/2023$87.00Perform → Outperform
    Oppenheimer
    3/15/2023$85.00Neutral → Overweight
    JP Morgan
    8/9/2022$72.00 → $75.00Buy → Neutral
    UBS
    More analyst ratings

    $HLNE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • New insider French River 5 Ltd claimed ownership of 480,015 shares and claimed ownership of 7 units of Class B Common Stock (SEC Form 3)

      3 - Hamilton Lane INC (0001433642) (Issuer)

      4/25/25 5:05:37 PM ET
      $HLNE
      Investment Managers
      Finance
    • Co-Chief Executive Officer Delgado-Moreira Juan was granted 34,031 shares, increasing direct ownership by 3% to 1,298,847 units (SEC Form 4)

      4 - Hamilton Lane INC (0001433642) (Issuer)

      3/18/25 5:00:47 PM ET
      $HLNE
      Investment Managers
      Finance
    • Co-Chief Executive Officer Hirsch Erik R. was granted 36,001 shares and covered exercise/tax liability with 3,386 shares, increasing direct ownership by 37% to 120,275 units (SEC Form 4)

      4 - Hamilton Lane INC (0001433642) (Issuer)

      3/18/25 4:58:27 PM ET
      $HLNE
      Investment Managers
      Finance

    $HLNE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

      SC 13G/A - Hamilton Lane INC (0001433642) (Subject)

      11/13/24 9:56:40 PM ET
      $HLNE
      Investment Managers
      Finance
    • Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

      SC 13G/A - Hamilton Lane INC (0001433642) (Subject)

      11/12/24 3:55:46 PM ET
      $HLNE
      Investment Managers
      Finance
    • Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

      SC 13G/A - Hamilton Lane INC (0001433642) (Subject)

      11/4/24 11:53:29 AM ET
      $HLNE
      Investment Managers
      Finance

    $HLNE
    SEC Filings

    See more
    • Amendment: SEC Form SCHEDULE 13D/A filed by Hamilton Lane Incorporated

      SCHEDULE 13D/A - Hamilton Lane INC (0001433642) (Subject)

      4/2/25 4:33:42 PM ET
      $HLNE
      Investment Managers
      Finance
    • Amendment: SEC Form SCHEDULE 13D/A filed by Hamilton Lane Incorporated

      SCHEDULE 13D/A - Hamilton Lane INC (0001433642) (Subject)

      2/14/25 4:27:12 PM ET
      $HLNE
      Investment Managers
      Finance
    • Hamilton Lane Incorporated filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - Hamilton Lane INC (0001433642) (Filer)

      2/12/25 4:21:19 PM ET
      $HLNE
      Investment Managers
      Finance

    $HLNE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Co-Chief Executive Officer Delgado-Moreira Juan bought $105,950 worth of shares (525 units at $201.81) (SEC Form 4)

      4 - Hamilton Lane INC (0001433642) (Issuer)

      11/13/24 4:31:06 PM ET
      $HLNE
      Investment Managers
      Finance

    $HLNE
    Leadership Updates

    Live Leadership Updates

    See more
    • Grenova Secures New Investment; Appoints Life Sciences Veteran to the Board

      Grenova, Inc., a Virginia-based innovator in sustainable laboratory technologies, today announced two significant milestones for the company: the appointment of Ted Hull to Grenova's board, and the successful completion of a new round of growth equity capital. These developments support Grenova's strategic vision to drive innovation, expand automation capabilities, and deliver transformative solutions to laboratories worldwide. Ted Hull brings over 30 years of experience in the life sciences industry, including as a clinical lab CEO for the last 20+ years. In his role at Grenova, Mr. Hull is set to provide strategic leadership and to play a pivotal role in shaping the company's future. "I

      4/23/25 8:00:00 AM ET
      $HLNE
      Investment Managers
      Finance
    • Cosette Pharmaceuticals Appoints Vincent Colicchio as Senior Vice President of Operations

      Industry leader with 35+ years of experience in manufacturing operations and global supply chain excellence Cosette Pharmaceuticals, Inc., a leading specialty pharmaceuticals company, today announced the appointment of Vincent (Vin) Colicchio as Senior Vice President of Operations, effective February 3, 2025. In this role, Vin will lead Cosette's manufacturing, global supply chain, and operational strategy, ensuring efficiency, and supply continuity as the company continues its strong trajectory of growth and transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250210366017/en/Senior Vice President, Operations (Photo

      2/10/25 8:00:00 AM ET
      $HLNE
      Investment Managers
      Finance
    • Cosette Pharmaceuticals Appoints Brad Leonard as Vice President, Generics Commercial Operation

      Experienced commercial leader joins Cosette to drive the next phase of growth and transformation Cosette Pharmaceuticals, Inc., a leading specialty pharmaceuticals company, today announced the appointment of Brad Leonard as Vice President, Generics Commercial Operations. In this role, Brad will spearhead Cosette's generics business, including Generics Sales, Marketing/Pricing, Customer Service, and Demand Planning, as the company continues its expansion in these markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250203104224/en/Brad Leonard, Vice President, Generics Commercial Operations (Photo: Business Wire) "Cosette is

      2/3/25 8:00:00 AM ET
      $HLNE
      Investment Managers
      Finance

    $HLNE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Hamilton Lane upgraded by Oppenheimer with a new price target

      Oppenheimer upgraded Hamilton Lane from Perform to Outperform and set a new price target of $186.00

      1/21/25 7:49:57 AM ET
      $HLNE
      Investment Managers
      Finance
    • Hamilton Lane downgraded by Goldman with a new price target

      Goldman downgraded Hamilton Lane from Neutral to Sell and set a new price target of $139.00

      1/6/25 8:11:18 AM ET
      $HLNE
      Investment Managers
      Finance
    • Wells Fargo initiated coverage on Hamilton Lane with a new price target

      Wells Fargo initiated coverage of Hamilton Lane with a rating of Equal Weight and set a new price target of $156.00

      9/12/24 7:41:15 AM ET
      $HLNE
      Investment Managers
      Finance

    $HLNE
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Hamilton Lane Incorporated to Announce Fourth Fiscal Quarter and Full Fiscal Year 2025 Results on May 29, 2025

      CONSHOHOCKEN, Pa., May 8, 2025 /PRNewswire/ -- Hamilton Lane Incorporated (NASDAQ:HLNE) is scheduled to release financial results for the fourth fiscal quarter and full fiscal year ended March 31, 2025 before the market opens on Thursday, May 29, 2025. A copy of the earnings release and full detailed presentation will be available on the Hamilton Lane Shareholders website at https://shareholders.hamiltonlane.com/. Hamilton Lane will host a conference call via webcast at 11:00 a.m. ET on May 29 to discuss the results for the fourth fiscal quarter and full fiscal year. For access to the live event via the webcast, visit Hamilton Lane's Shareholder's website by clicking here (https://sharehold

      5/8/25 7:00:00 AM ET
      $HLNE
      Investment Managers
      Finance
    • Hamilton Lane Launches U.S. Venture Capital and Growth Evergreen Fund, Further Expanding its $10B+ AUM Evergreen Platform

      Fund offers access to private venture and growth investments including disruptive technologies and innovative businesses CONSHOHOCKEN, Pa., May 6, 2025 /PRNewswire/ -- Leading private markets investment firm Hamilton Lane (NASDAQ:HLNE) today announced the launch of the Hamilton Lane Venture Capital and Growth Fund ("HLVCG" or "the Fund"), a continuously offered evergreen investment vehicle registered under the Investment Act of 1940 ("40 Act"), available to accredited U.S. investor clients, including high-net-worth investors and their advisors2, as well as institutional investors. HLVCG offers investors in the U.S. access to the firm's global venture capital investment platform with what th

      5/6/25 7:00:00 AM ET
      $HLNE
      Investment Managers
      Finance
    • Grenova Secures New Investment; Appoints Life Sciences Veteran to the Board

      Grenova, Inc., a Virginia-based innovator in sustainable laboratory technologies, today announced two significant milestones for the company: the appointment of Ted Hull to Grenova's board, and the successful completion of a new round of growth equity capital. These developments support Grenova's strategic vision to drive innovation, expand automation capabilities, and deliver transformative solutions to laboratories worldwide. Ted Hull brings over 30 years of experience in the life sciences industry, including as a clinical lab CEO for the last 20+ years. In his role at Grenova, Mr. Hull is set to provide strategic leadership and to play a pivotal role in shaping the company's future. "I

      4/23/25 8:00:00 AM ET
      $HLNE
      Investment Managers
      Finance

    $HLNE
    Financials

    Live finance-specific insights

    See more
    • Hamilton Lane Incorporated to Announce Fourth Fiscal Quarter and Full Fiscal Year 2025 Results on May 29, 2025

      CONSHOHOCKEN, Pa., May 8, 2025 /PRNewswire/ -- Hamilton Lane Incorporated (NASDAQ:HLNE) is scheduled to release financial results for the fourth fiscal quarter and full fiscal year ended March 31, 2025 before the market opens on Thursday, May 29, 2025. A copy of the earnings release and full detailed presentation will be available on the Hamilton Lane Shareholders website at https://shareholders.hamiltonlane.com/. Hamilton Lane will host a conference call via webcast at 11:00 a.m. ET on May 29 to discuss the results for the fourth fiscal quarter and full fiscal year. For access to the live event via the webcast, visit Hamilton Lane's Shareholder's website by clicking here (https://sharehold

      5/8/25 7:00:00 AM ET
      $HLNE
      Investment Managers
      Finance
    • PAX Health Acquires Richardson Psychiatric Associates, Expanding Mental Health Services for Adults, Adolescents, and Families

      RED BANK, N.J., April 17, 2025 /PRNewswire/ -- PAX Health, a leading behavioral healthcare company backed by HCAP Partners and funds managed by Hamilton Lane (NASDAQ:HLNE), today announced its acquisition of Richardson Psychiatric Associates, a comprehensive outpatient psychiatric practice serving adults, adolescents, children, and families. This strategic acquisition enhances PAX Health's portfolio of mental health services and expands its geographic footprint in Western Pennsylvania, strengthening the company's ability to deliver high-quality psychiatric care across diverse

      4/17/25 8:27:00 AM ET
      $HLNE
      Investment Managers
      Finance
    • HAMILTON LANE INCORPORATED REPORTS THIRD QUARTER FISCAL 2025 RESULTS, WITH MANAGEMENT & ADVISORY FEES GROWING BY 11% AND ASSETS UNDER MANAGEMENT GROWING BY 12% YEAR-OVER-YEAR

      CONSHOHOCKEN, Pa., Feb. 4, 2025 /PRNewswire/ -- Leading private markets asset management firm Hamilton Lane Incorporated (NASDAQ:HLNE) today reported its results for the third fiscal quarter ended December 31, 2024. THIRD QUARTER FISCAL 2025 HIGHLIGHTS Assets under management – Total assets under management of $134.7 billion grew $14.8 billion year-over-year. Fee-earning assets under management increased $7.9 billion to $71.0 billion over the same period.Revenue – Management and advisory fees of $126.3 million for the quarter represent growth of 11% versus the prior year period.Carried Interest – Unrealized carried interest balance of approximately $1.3 billion, up 15% versus the prior year

      2/4/25 7:00:00 AM ET
      $HLNE
      Investment Managers
      Finance